April 8, 2024

Transcatheter or Surgical Treatment of Aortic-Valve Stenosis

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lacking on the appropriate treatment strategy in routine clinical practice.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Blankenberg et al. (Mon,) studied this question.

synapsesocial.com/papers/68e6febab6db6435876792e3 https://doi.org/https://doi.org/10.1056/nejmoa2400685

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients2019 · 4,778 citations
2Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document†2012 · 1,037 citations
3Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials2023 · 105 citations
4Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement2020 · 820 citations
5Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?2022 · 109 citations

Preguntar a la IA

Me gusta

Guardar